Patient
SITE009-0145
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE009 (AUS) (Dr. Novak)
consented 2026-02-10
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 3
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-01-20 (study day 147); relationship: NOT RELATED
Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-11-20 (study day 86); relationship: not assessed
Grade 1 Stomatitis — outcome: UNKNOWN; onset 2022-11-12 (study day 78); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.